DCGI grants Cipla emergency use authorisation for COVID-19 drug Molnupiravir \
2 min read
\
\

DCGI grants Cipla emergency use authorisation for COVID-19 drug Molnupiravir

28-Dec-2021
Mumbai (Maharashtra) [India], December 28 (ANI): Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment.
28-Dec-2021 National
\